Over half (53%) of affluent investors worldwide expect to live till the age of 100 years, triggering the need to make financial changes, according to a report by UBS.
The UBS Investor Watch, which surveyed more than 5,000 investors with at least $1m of investable assets, found US investors to be the least optimistic in this regard compared to Asia and continental Europe.
The study revealed increasing healthcare costs to be the biggest concern for wealthy investors expecting increased life expectancy. This concern was found to be more pronounced among US investors, with 69% of them voicing the concern compared to 52% of global investors.
Moreover, 75% of US investors were found planning to make financial changes owing to increased life expectancy compared to 91% globally. As long-term investments, US investors preferred equities and real estate, while investors globally favoured cash.
Also, 46% of US investors said they plan to give more wealth away while they are alive, as against 62% globally.
The study also found good health getting preference over abundant wealth from both global and US investors. Ninety one percent of US investors said that their wealth allows them to live a healthier life, compared to 92% of investors globally.
UBS Global Wealth Management global client strategy officer and group managing director Paula Polito said: “As much as investors look forward to living 100 years, the prospect is creating anxiety for them, too.
“Despite being wealthy, they still worry about difficult choices they may face, such as spending a portion of their children’s inheritance to pay for healthcare, or working longer to sustain their lifestyle over time. Already, we are starting to see longevity change long-practiced financial behaviors.”